Annual savings from FDA generic drug approvals have reached $445 billion in 2023, with year-to-year variations driven by patent expirations of blockbuster drugs. This breakdown shows how generic competition cuts drug costs across the U.S. healthcare system.
Read More
Urate Targets in Gout: How Allopurinol and Febuxostat Strategies Work
mRNA Therapeutics: Side Effects and Post-Approval Monitoring
Annual Savings from FDA Generic Drug Approvals: Year-by-Year Breakdown
Hypophosphatemia and GI Symptoms: Causes, Diagnosis, and Treatment
Urticaria: Hives, Common Triggers, and How Antihistamines Really Work
